Lot 21 Rituximab Biosimilar ose origjinator
| Contracted Institution | Ministry of Health | ||||||||||||
| Tenderer Institution | Ministry of Health | ||||||||||||
| Tender object | Lot 21 Rituximab Biosimilar ose origjinator | ||||||||||||
| Reference No. | REF-03298-05-02-2024 | ||||||||||||
| Estimated / Ceiling Value ALL without VAT | 12 611 109,00 | ||||||||||||
| Type of Contract | |||||||||||||
| Procurement Method | Open Procedure above the high monetary limit | ||||||||||||
| Stage Procedure | Announced the Winner | ||||||||||||
| Tender Publication Date | 03-05-2024 | ||||||||||||
| Last date of Submitted Documents | 03-06-2024 | ||||||||||||
| Tender Held Date | 03-06-2024 | ||||||||||||
| No. of Bidders | 4 | ||||||||||||
| Bidders |
1. PEGASUS. shpk 2. EDNA - FARMA shpk 3. DELTA PHARMA - AL shpk 4. MEGAPHARMA shpk |
||||||||||||
| Successful Bidder /Supplier / Provider |
|
||||||||||||
| The winning bid ALL without vat | 7 423 500,00 | ||||||||||||
| Bidder Announcement date | 08-07-2024 | ||||||||||||
| Award and Contract Amount ALL with VAT | |||||||||||||
| Contract date | |||||||||||||
| Planned Milestones of Contract / Start and End Date | Kontratat mund të lidhen nga AK përfituese brenda afatit 24 muaj nga data e nënshkrimit të MK nga palët, për secilin lot. | ||||||||||||
| Renewal Contract Additional Value (ALL with VAT) |
|
||||||||||||
| Appeals | Nuk ka operatore ekonomike te skualifikuar. | ||||||||||||
| Cancellation reason | |||||||||||||
| Additions | |||||||||||||
| Transaction / Actual Spending |
|
||||||||||||
| Public Announcement Bulletin |
|